Cardio Diagnostics Holdings, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Cardio Diagnostics Holdings, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
No changes.
No changes.
—
Expected move
No implied move.
Annual filing, covered
10-K parsed · Mar 13 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 13 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Same SIC code · 6
Same SEC industry code: Idexx Laboratories Inc, Lantheus Holdings, Inc., Celldex Therapeutics, Inc. and 3 more; no measured co-movers for Cardio Diagnostics Holdings, Inc..
Same SIC code · 6
Same SEC industry code: Idexx Laboratories Inc, Lantheus Holdings, Inc., Celldex Therapeutics, Inc. and 3 more; no measured co-movers for Cardio Diagnostics Holdings, Inc..
Largest filed tie
0
filed ties
—
No thesis.
Mana Capital Acquisition Corp. focuses on engaging in a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to focus on businesses operating in the healthcare, technology, green economy, and consumer products sectors in North America, Europe, and Asia. The company was incorporated in 2021 and is based in Dover, Delaware.
Mana Capital Acquisition Corp. focuses on engaging in a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to focus on businesses operating in the healthcare, technology, green economy, and consumer products sectors in North America, Europe, and Asia. The company was incorporated in 2021 and is based in Dover, Delaware.
Cardio Diagnostics Holdings, Inc.
1.63
−0.04 · −2.40%
post 1.62 −0.61%
No trades yet today.
No trades yet today.
| Manager | Value | % base | |
|---|---|---|---|
| Renaissance Technologies | $107,748 | 25.49% | +220.56% |
| BlackRockindex-like | $76,011 | 17.98% | 0.00% |
| Geodeindex-like | $57,449 | 13.59% | −18.47% |
| Vanguardindex-like | $44,139 | 10.44% | 0.00% |
| Citadel | $41,765 | 9.88% | new |
| Manager | Value | % base | |
|---|---|---|---|
| Renaissance Technologies | $107,748 | 25.49% | +220.56% |
| BlackRockindex-like | $76,011 | 17.98% | 0.00% |
| Geodeindex-like | $57,449 | 13.59% | −18.47% |
| Vanguardindex-like | $44,139 | 10.44% | 0.00% |
| Citadel | $41,765 | 9.88% | new |
−26.12%
shares held · 10 largest managers